Cryoimmunology for malignant bone and soft-tissue tumors
Hideji Nishida1, Norio Yamamoto, Yoshikazu Tanzawa
1Department of Orthopaedic Surgery, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan. hideji0511@yahoo.co.jp
Abstract:
Several new methods have recently been developed for the treatment of malignant bone and soft-tissue tumors, and many of these targeted therapies have yielded promising initial results in clinical settings. As more sarcomas become amenable to effective molecular-targeting therapy, the need to evaluate the synergistic effects of combination therapies with anticancer drugs will grow. Other immunologic therapies have also been reported, such as exogenous cytokines, dendritic cell (DC) therapy and peptide vaccines. Cryoimmunology has shown promising results in some malignant tumors after cryosurgery and is expected to influence the next generation of tumor immunotherapy. In this report, we describe the induction of a systemic antitumor immune response following liquid nitrogen cryotreatment of a destructive murine osteosarcoma. Combining tumor cryotreatment with DCs to promote tumor-specific immune responses enhanced systemic immune responses and inhibited metastatic tumor growth. We also describe the induction of a systemic antitumor immune response following reconstruction for malignant bone tumors using frozen autografts treated with liquid nitrogen.
Insights
Liquid nitrogen cryotreatment of osteosarcoma in mice induced a systemic antitumor immune response. Combining cryotreatment with dendritic cell (DC) therapy enhanced immune responses and inhibited metastatic tumor growth.
Area of Science:
- Oncology
- Immunology
- Cryobiology
Background:
- Emerging targeted therapies show promise for malignant bone and soft-tissue tumors.
- Combination therapies and immunotherapies like dendritic cell (DC) therapy are increasingly important.
- Cryoimmunology presents a novel approach for next-generation tumor immunotherapy.
Purpose of the Study:
- To investigate the induction of systemic antitumor immune responses following liquid nitrogen cryotreatment of murine osteosarcoma.
- To evaluate the efficacy of combining tumor cryotreatment with DC therapy in enhancing antitumor immunity and inhibiting metastasis.
- To explore the induction of systemic antitumor immune responses after reconstruction using cryotreated autografts.
Main Methods:
- Cryotreatment of a destructive murine osteosarcoma using liquid nitrogen.
- Combination therapy involving tumor cryotreatment and administration of dendritic cells (DCs).
- Assessment of systemic antitumor immune responses and metastatic tumor growth inhibition.
Main Results:
- Liquid nitrogen cryotreatment alone induced a systemic antitumor immune response.
- Combining cryotreatment with DCs significantly enhanced systemic immune responses.
- The combination therapy effectively inhibited metastatic tumor growth.
Conclusions:
- Cryoimmunology, specifically liquid nitrogen cryotreatment, can induce systemic antitumor immunity.
- Combining cryotreatment with DC therapy is a promising strategy for enhancing antitumor responses and controlling metastatic disease.
- Cryotreatment of autografts may also contribute to systemic antitumor immunity in bone tumor reconstruction.
